.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Novartis
Harvard Business School
Boehringer Ingelheim
Covington
QuintilesIMS
Chinese Patent Office
US Department of Justice
McKinsey
UBS

Generated: January 21, 2018

DrugPatentWatch Database Preview

Drug Master Files for: CALCIUM CHLORIDE; DEXTROSE; SODIUM CHLORIDE; SODIUM LACTATE

« Back to Dashboard


DMF No. Status Type Submission Date Holder Subject
226III5/24/1956BRISTOL LABORATORIES INC DIV BRISTOL MYERS COCALCIUM AMPHOMYCIN OINTMENT
433III5/12/1961H LUNDBECK AND CO ASCALCIUM - AMPHOMYCIN
778III1/24/1964GANES CHEMICALS INC PENNSVILLE DIVCALCIUM PHENOBARBITAL
31374AIII10/17/2017ZIGNAGO VETRO SPAHOLLOW GLASS CONTAINER MATERIAL: SODIC CALCIUM GLASS
1262III12/16/1968GENERAL ELECTRIC COCALCIUM 45, PRODUCT SPECIFICATIONS AND PROCESS DESCRIPTIONS
1263III12/16/1968GENERAL ELECTRIC COCALCIUM-47
1311I1/13/1969GEIGY PHARMSCALCIUM CHEL 330
1324III2/7/1969COLONIAL SUGAR REFINING CO LTDCALCIUM SUCROSE PHOSPHATES (ANTICAY)
1525III5/11/1970ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIVMANUF, PACKAGING AND LABELING OF BULK CALCIUM AND SODIUM CYCLAMATE
1728I6/9/1971AMERICAN CYANAMID CODIOCTYL CALCIUM SULFOSUCCINATE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
QuintilesIMS
AstraZeneca
McKesson
Johnson and Johnson
Argus Health
Daiichi Sankyo
UBS
Fuji
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot